SOX2 (3q26.33) amplification has been found in 15% of ESCC and it has been postulated that its downregulation may inhibit ESCC carcinogenesis and improve the efficacy of chemotherapy [25,29,55]. The gene discussed is SOX2; the disease is esophageal squamous cell carcinoma.